Yuan Hao, Ma Peng-Wei, Chen Jia-Wei, Wang Wei-Long, Gao Wei, Lu Pei-Heng, Ding Xue-Rui, Lun Yu-Qiang, Wang Zi, Lu Lian-Jun
Department of Otolaryngology Head and Neck Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Front Neurol. 2024 Dec 9;15:1515953. doi: 10.3389/fneur.2024.1515953. eCollection 2024.
This study explored the clinical characteristics of patients with tinnitus who responded to sound therapy and established a predictive model to evaluate the effectiveness of this therapy according to the clinical characteristics.
A retrospective analysis was performed on 991 subjective tinnitus patients who received compound sound therapy in the Department of Otolaryngology of the local hospital from November 2019 to January 2022.
We found that tinnitus patients with different therapeutic effects had significant differences in the tinnitus side ( = 0.007), tone loudness distortion feedback test (FBT) ( = 0.000), residual inhibition test (RIT) ( = 0.000), tinnitus frequency ( = 0.012) and sensation level ( = 0.023). The corresponding variables were screened by univariate logistic regression, and the selected variables were analyzed using multivariate logistic regression. The results showed that FBT ( = 0.003), RIT ( = 0.000) and tinnitus frequency ( = 0.029) were independent risk factors affecting the efficacy of compound sound therapy. A predictive model and nomogram for the efficacy of compound sound therapy for tinnitus were constructed based on independent risk factors. The area under the curve (AUC) of the model constructed in this study was 0.766 (95% CI = 0.725-0.807), indicating a certain prediction ability. The calibration curve revealed that the predicted results were in good agreement with the actual results.
The model can predict the prognosis of tinnitus in patients receiving compound sound therapy and help otolaryngologists make the best clinical decisions regarding tinnitus treatment.
本研究探讨了对声音疗法有反应的耳鸣患者的临床特征,并根据临床特征建立了一个预测模型,以评估该疗法的有效性。
对2019年11月至2022年1月在当地医院耳鼻喉科接受复合声音疗法的991例主观性耳鸣患者进行回顾性分析。
我们发现,不同治疗效果的耳鸣患者在耳鸣侧别(P = 0 . 007)、音调响度畸变反馈测试(FBT)(P = 0 . 000)、残余抑制测试(RIT)(P = 0 . 000)、耳鸣频率(P = 0 . 012)和感觉水平(P = 0 . 023)方面存在显著差异。通过单因素逻辑回归筛选相应变量,并使用多因素逻辑回归分析所选变量。结果显示,FBT(P = 0 . 003)、RIT(P = 0 . 000)和耳鸣频率(P = 0 . 029)是影响复合声音疗法疗效的独立危险因素。基于独立危险因素构建了耳鸣复合声音疗法疗效的预测模型和列线图。本研究构建的模型曲线下面积(AUC)为0 . 766(95%CI = 0 . 725 - 0 . 807),表明具有一定的预测能力。校准曲线显示预测结果与实际结果吻合良好。
该模型可以预测接受复合声音疗法的耳鸣患者的预后,并帮助耳鼻喉科医生做出关于耳鸣治疗的最佳临床决策。